Table 2.
Intrapancreatic DC, macrophages, and B cells in NOD mice
| Phenotype | Demonstrated or proposed role/function | Concomitant events inside pancreas | |
|---|---|---|---|
| DC | XCR1+ CD103+ Batf3+ | Increase in numbers beginning at 3 weeks of age | Insulin-reactive CD4+ T cells evident inside the pancreas and around the islets |
| CD103+ DC cross present class I MHC epitopes to CD8+ T cells, and Batf3 is necessary for this function | Insulin-reactive T cells are in tight physical contact with the CD103+ DC, which exhibit an interferon-inducible gene expression signature | ||
| Batf3-deficient NOD mice | XCR1+ CD103+ DC were absent in the islets, transgenic mice remained diabetes free and without evidence of islet-reactive T cells; poor priming of diabetogenic CD4 and CD8 T-cell responses | ||
| Macrophages | Derive from hematopoietic progenitors, slow replicating, not replaced by circulating monocytic precursors | Filopodia extend into the microvasculature | Deletion of islet-resident macrophages eliminated T-cell entry into islets and reduced diabetes incidence in NOD mice |
| Exhibit a proinflammatory gene signature | Sense blood-borne molecules | ||
| Resemble lung “barrier macrophages” with high lysosomal content and activity | Physically adjacent to β-cells and take up insulin-containing crinosomes |